Vitamin D and the Atopic March

The "atopic march" describes the typical progression of allergic disease in childhood — infant eczema, followed by food allergy, then asthma, then allergic rhinitis. Vitamin D deficiency has been examined as a modifiable factor across this cascade. Evidence is strongest for prenatal supplementation and infant wheeze; weaker for later stages.

Prenatal trials — VDAART and COPSAC

Two landmark 2016 trials tested high-dose maternal vitamin D vs standard prenatal vitamin D for offspring allergic disease:

Infant eczema

Small trials of infant vitamin D supplementation show modest SCORAD improvement in infants with eczema and vitamin D deficiency. Broader preventive effect is unclear. Standard 400 IU/day for breastfed infants (AAP) is standard care regardless.

Food allergy

Ecological data — food allergy rates correlate with latitude — suggests possible vitamin D role in food allergy pathogenesis. The Australian HealthNuts study found vitamin D-deficient infants had higher peanut allergy rates. Supplementation trial evidence is limited. Early introduction of allergenic foods (LEAP-style peanut protocol) is the established evidence-based food allergy prevention intervention.

Practical guide

  1. Pregnancy: ensure adequate vitamin D (600-4,000 IU/day per obstetric guidance). Higher-end dosing may reduce infant wheeze.
  2. Breastfed infants: 400 IU/day cholecalciferol drops (AAP standard). See our infants page.
  3. Toddlers with eczema: standard age-appropriate dosing; correct any deficiency.
  4. Food-allergy prevention: follow early-introduction guidance; vitamin D is not a substitute.
Sponsored
Not medical advice. Persistent atopic disease benefits from allergology/dermatology specialist care — supplements are supportive, not curative.

Related tools & guides

Advertisement